Panacea Biotec Limited

Web: panaceabiotec.com NSE: PANACEABIO BSE: 531349 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

384 5(-1%)

Volume

1L as on 22, Jan

Open

374

High

379

Low

371

389

VWAP

369

52 Week High

647

52 Week Low

292

Viand Research Rating

Quality Score

51/100

Growth Score

47/100

Valuation Score

50/100

Momentum Score

25/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

2,352

No. of Shares

6.13

P/E

-194.13

P/B

7.92

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

-4.08

ROCE

Profit Growth

Listing Date

17-Apr-96

Promoter Holding

72.48%

FII Holding

2.31%

DII Holding

2.25%

Price Chart

Price Performance

1 Week6%

1 Month3%

3 Months17%

6 Months12%

1 Year4%

YTD2%

Moving Average

5 Day SMA381

10 Day SMA395

20 Day SMA387

30 Day SMA375

50 Day SMA370

61 Day SMA380

80 Day SMA392

200 Day SMA428

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	409	369	397	411
Resistance 2	397	366	385	397
Resistance 1	379	363	378	380
Pivot Point	366	361	366	367
Support 1	348	358	355	350
Support 2	336	355	348	337
Support 3	318	352	336	319

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 72.48%	(0.01) 72.48%	(0.01) 72.48%	(0.01) 72.48%	(0.01) 72.48%	(0.01) 72.48%	(-0.41) 72.49%	(-0.61) 72.87%	(-0.11) 73.47%	(0.01) 73.59%	(0.01) 73.59%	(0.01) 73.59%	(0.01) 73.59%	(0.01) 73.59%	(0.01) 73.59%	(0.01) 73.59%	(0.01) 73.59%	(0.01) 73.59%	(0.01) 73.59%	(0.01) 73.59%
FIIs	(0.71) 2.31%	(0.21) 1.60%	(0.31) 1.36%	(0.31) 1.06%	(-0.41) 0.79%	(0.81) 1.16%	(0.01) 0.38%	(0.11) 0.37%	(0.01) 0.26%	(0.01) 0.27%	(0.01) 0.26%	(0.01) 0.26%	(0.01) 0.22%	(0.01) 0.18%	(0.01) 0.18%	(0.11) 0.14%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.02%
DIIs	(0.31) 2.25%	(0.11) 1.96%	(0.11) 1.85%	(0.31) 1.80%	(0.01) 1.52%	(0.31) 1.49%	(0.01) 1.16%	(0.11) 1.16%	(0.21) 1.07%	(0.21) 0.84%	(0.11) 0.69%	(0.01) 0.57%	(0.11) 0.54%	(0.01) 0.43%	(0.11) 0.43%	(0.31) 0.29%	(0.01) 0.00%	(-0.11) 0.00%	(-0.31) 0.13%	(0.01) 0.40%
Public	22.96%	23.96%	24.31%	24.65%	25.20%	24.86%	25.96%	25.60%	25.21%	25.30%	25.46%	25.58%	25.66%	25.80%	25.81%	25.98%	26.41%	26.41%	26.28%	25.99%
No. of Shareholders	33,532	32,620	34,597	33,593	34,256	33,593	35,446	39,982	45,513	46,242	47,091	48,878	47,815	48,634	50,533	49,078	49,896	49,563	52,465	52,816

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	199.57	166.75	165.19	141.13	166.7	132.53	163.49	147.35	115.72	136.46	150.5	143.02	129.19	128.93	115.2	105	110.7	140.73	155.88	232.17	132
Sales Growth % (YoY)	19.7%	25.8%	1%	-4.2%	44%	-2.9%	8.6%	3%	-10.4%	5.8%	30.6%	36%	16.7%	-8.4%	-26.1%	-54.7%	-16.4%	-16.4%	10%	27.6%	-0.2%
Sales Growth % (QoQ)	19.7%	0.9%	17%	-15.3%	25.8%	-18.9%	11%	27.3%	-15.2%	-9.3%	5.2%	10.7%	0.2%	11.9%	9.7%	-5.1%	-21.3%	-9.7%	-32.9%	75.9%	-
Expenses	193.9	164.18	153.45	158.92	167.88	159.41	155.53	140.35	129.71	142.5	150.65	146.58	139.5	134.6	123.84	109	190.51	170.92	144.02	226.15	134
Operating Profit	5.67	2.57	11.74	-17.79	-1.18	-26.88	7.96	7	-13.99	-6.04	-0.15	-3.56	-10.31	-5.67	-8.64	-4	-79.81	-30.19	11.86	6.02	-2
OPM %	2.84	1.54	7.11	-12.61	-0.71	-20.28	4.87	4.75	-12.09	-4.43	-0.1	-2.49	-7.98	-4.4	-7.5	-4	-72.1	-21.45	7.61	2.59	-1
Other Income	6.98	5.26	5.05	9.1	16.99	36.3	6.39	7.42	6.54	13.55	8.46	6	33.82	34.44	41.71	38	39.95	1680.26	1.66	2.03	3
Interest	1.18	1.2	1.85	2.14	0.86	1.04	0.99	0.98	0.87	0.82	0.85	0.91	1	1.05	0.96	1	1.25	30.66	52.13	50.16	48
Depreciation	7.9	7.88	8.45	8.34	8.39	8.42	8.98	8.68	8.73	8.81	9.11	9.31	9.48	9.51	9.67	10	10.05	11.15	10.55	10.9	11
Profit before tax	3.57	-1.25	6.49	-19.17	6.56	-0.04	4.38	4.76	-17.05	-2.12	-1.65	-7.78	13.03	18.21	22.44	23	-51.16	1608.26	-49.16	-53.01	-57
Tax %	38.38	-20	40.06	-26.92	39.63	4875	-1.37	1.05	-6.86	-6.13	33.33	6.56	15.73	169.63	13.68	33	9.73	23.06	0.08	0	0
Net Profit	2.2	-1	3.89	-14.01	3.96	-1.99	4.44	4.71	-15.88	-1.99	-2.2	-8.29	10.98	-12.68	19.37	16	-56.14	1237.47	-49.2	-53.01	-57
Net Profit Growth % (QoQ)	320%	-125.7%	127.8%	-453.8%	299%	-144.8%	-5.7%	129.7%	-698%	9.5%	73.5%	-175.5%	186.6%	-165.5%	21.1%	128.5%	-104.5%	2615.2%	7.2%	7%	-
Net Profit Growth % (YoY)	-44.4%	49.7%	-12.4%	-397.5%	124.9%	-	301.8%	156.8%	-244.6%	84.3%	-111.4%	-151.8%	119.6%	-101%	139.4%	130.2%	1.5%	-	-	-	-
TTM Net Profit	-8.92	-7.16	-8.15	-7.6	11.12	-8.72	-8.72	-15.36	-28.36	-1.5	-12.19	9.38	33.67	-33.45	1216.7	1148.13	1079.12	1078.26	-159.21	-110.01	0
EPS in Rs	0.38	0.08	0.65	-2.27	0.66	-0.31	0.74	0.78	-2.58	-0.32	-0.37	-1.35	1.79	-2.07	3.16	2.56	-9.16	201.86	-8.03	-8.65	-9.36

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	640	559	559	460	661	625	544	457	593	544	653	687	510	608
Sales Growth %	14.4%	0%	21.6%	-30.4%	5.8%	14.8%	19.1%	-23%	9%	-16.7%	-5%	34.8%	-16.2%	-14.3%
Expenses	644	584	579	558	674	548	484	591	509	505	541	643	582	665
Operating Profit	-5	-25	-20	-98	-13	77	60	-134	84	39	112	44	-72	-56
OPM %	-0.7	-4.4	-3.5	-21	-2	12	11	-29	14	7	17	6	-14	-9
Other Income	36	55	62	154	1687	9	-21	338	8	62	70	28	183	-7
Interest	6	4	4	4	181	185	174	105	101	101	127	105	150	104
Depreciation	33	35	37	39	44	46	43	54	57	68	73	67	71	86
Profit before tax	-7	-8	1	13	1449	-146	-178	45	-66	-67	-19	-99	-111	-253
Tax %	-3	10	201	363	26	1	9	17	15	-16	10	3	2	-7
Net Profit	-7	-9	-2	-34	1078	-148	-194	38	-76	-56	-21	-108	-113	-234
Net Profit Growth %	22.2%	-350%	94.1%	-103.2%	828.4%	23.7%	-610.5%	150%	-35.7%	-166.7%	80.6%	4.4%	51.7%	-
EPS in Rs	-0.88	-1.37	-0.19	-5.42	175.91	-24.09	-31.69	6.15	-12.07	-8.89	-2.98	-17.38	-18.29	-38.22
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	17	-27	0	-422	-108	107	-30	105	118	131	91	37	54	-24
Cash from Investing Activity	-40	65	10	430	1283	-48	-35	-6	55	-26	16	-37	-38	-61
Cash from Financing Activity	-1	-3	-3	-18	-1176	-47	91	-101	-164	-107	-117	-1	-30	105
Net Cash Flow	-25	35	7	-10	-2	12	26	-2	9	-2	-10	-1	-14	20

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6	6
Reserves	829	820	829	827	836	837	871	-235	193	344	303	350	426	449	507	620
Borrowings	24	23	22	22	21	20	34	820	742	646	941	994	1105	1111	1060	979
Other Liabilities	404	405	433	389	378	407	848	587	449	379	349	440	317	364	371	235
Total Liabilities	1262	1254	1290	1243	1241	1271	1759	1178	1390	1376	1598	1789	1854	1930	1943	1839
Fixed Assets	620	594	567	597	582	600	622	609	657	806	949	1001	1071	1144	1276	1154
CWIP	100	110	128	84	102	42	17	34	24	23	40	30	161	155	172	135
Investments	10	3	3	37	40	13	5	0	6	5	7	7	9	15	16	22
Other Assets	532	547	592	525	517	615	1114	534	703	542	602	750	614	616	479	527
Total Assets	1262	1254	1290	1243	1241	1271	1759	1178	1390	1376	1598	1789	1854	1930	1943	1839

Delivery

Delivery Data: PANACEABIO

#	Date	370 61% 597	Value (Cr)	Q/T 38	Del 46	Del 8
1	4-Sep	381	2	27	63	1
2	3-Sep	389	4	31	51	2
3	2-Sep	382	12	38	52	6
4	1-Sep	391	4	42	60	3
5	31-Aug	387	4	36	56	2
6	28-Aug	396	4	31	40	1
7	27-Aug	393	3	36	59	2
8	26-Aug	398	3	35	65	2
9	25-Aug	406	2	28	49	1
10	24-Aug	406	2	26	55	1
11	21-Aug	411	5	28	46	2
12	20-Aug	414	8	32	55	4
13	19-Aug	403	4	26	43	2
14	18-Aug	406	7	36	53	3
15	17-Aug	413	8	29	41	3
16	14-Aug	396	10	30	38	4
17	13-Aug	414	10	38	54	5
18	12-Aug	400	9	56	65	6
19	11-Aug	402	4	39	59	2
20	10-Aug	404	6	38	64	4
21	7-Aug	413	6	36	53	3
22	6-Aug	419	8	37	44	4
23	5-Aug	419	14	35	38	5
24	4-Aug	419	10	47	49	5
25	3-Aug	423	3	22	56	2
26	31-Jul	421	7	41	50	3
27	30-Jul	414	5	32	45	2
28	29-Jul	424	6	29	46	3
29	28-Jul	414	8	39	46	4
30	27-Jul	433	5	19	38	2
31	24-Jul	441	8	30	37	3
32	23-Jul	445	13	25	34	4
33	22-Jul	462	32	28	40	13
34	21-Jul	494	34	50	41	14
35	20-Jul	549	6	31	41	3
36	17-Jul	549	12	27	37	4
37	16-Jul	564	27	29	35	10
38	15-Jul	538	4	24	41	1
39	14-Jul	538	3	25	45	1
40	13-Jul	542	4	25	45	2
41	10-Jul	547	6	28	46	3
42	9-Jul	555	20	30	46	9
43	8-Jul	527	12	27	35	4
44	7-Jul	538	9	30	32	3
45	6-Jul	535	14	37	41	6
46	3-Jul	551	10	39	32	3
47	2-Jul	548	12	30	26	3
48	1-Jul	543	55	36	28	16
49	30-Jun	566	34	34	26	9
50	29-Jun	554	19	30	28	5

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	2,352c	43c	1.79
03-Sep	2,395c	16c	0.67
01-Sep	2,379c	29c	1.18
31-Aug	2,408c	12c	0.49
27-Aug	2,419c	53c	2.16
26-Aug	2,473c	3c	0.10
25-Aug	2,475c	15c	0.59
24-Aug	2,490c	10c	0.38
21-Aug	2,480c	8c	0.31
19-Aug	2,473c	19c	0.75
18-Aug	2,491c	39c	1.55
17-Aug	2,531c	100c	4.12
14-Aug	2,430c	118c	4.64
13-Aug	2,549c	111c	4.55
12-Aug	2,438c	98c	3.86
10-Aug	2,536c	92L	0.04
07-Aug	2,537c	61c	2.33
06-Aug	2,597c	19c	0.72
04-Aug	2,579c	20c	0.78
03-Aug	2,559c	14c	0.54
31-Jul	2,573c	39c	1.55
30-Jul	2,533c	56c	2.15
29-Jul	2,589c	48c	1.87
28-Jul	2,542c	120c	4.52
27-Jul	2,662c	0	0

Stock Checklist

Price is above from 52 week high low average: 26%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Aug26 · Total value ₹0 Cr · 2 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.05%	+0.02%	0

Panacea Biotec Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements